Menopause Hormone Therapy
Hormone Replacement Therapy for Menopause: The Complete Guide
What every woman should know about hormone replacement therapy for menopause: the evidence, the options, and the path to restored vitality.
Introduction
More than 1 million women enter menopause each year in the United States, yet many receive little formal medical guidance during this transition. Menopause is a universal biological transition experienced by every woman, yet the impact of this transition varies widely. For many women, the hormonal changes that accompany menopause affect sleep, mood, cognition, metabolism, cardiovascular health, bone density, and overall vitality.
For decades, hormone replacement therapy for menopause—including bioidentical hormone replacement therapy (BHRT)—has been recognized as the most effective treatment for symptoms associated with this transition. However, confusion following early interpretations of the Women's Health Initiative study led many women and physicians to avoid treatment—even when symptoms were severe.
Today, the scientific understanding of menopause and hormone replacement therapy has evolved substantially. Major medical societies—including The Menopause Society, the American College of Obstetricians and Gynecologists (ACOG), and the Endocrine Society—recognize hormone therapy and BHRT as effective treatments for menopausal vasomotor symptoms in appropriate candidates.
At Metriq Health, menopause care is delivered through a physician‑led precision medicine model: the right hormones, the right delivery method, the right timing, and careful monitoring designed to optimize both symptom relief and long‑term healthspan.
Understanding Menopause
Menopause is defined as the point when a woman has gone 12 consecutive months without a menstrual period. The average age in the United States is approximately 51.
However, menopause represents just one point within a broader hormonal transition that begins years earlier during perimenopause. During this time, ovarian hormone production becomes increasingly irregular before eventually declining permanently.
More than one million women enter menopause each year in the United States. For many, this transition brings symptoms that meaningfully affect quality of life, work performance, relationships, and long‑term health.
Perimenopause vs. Menopause
Perimenopause refers to the transitional years leading up to menopause when hormone levels fluctuate unpredictably.
Common perimenopause symptoms may include:
- Irregular menstrual cycles
- Early sleep disruption
- Mood variability or anxiety
- Intermittent hot flashes
- Cognitive fog or reduced concentration
Because hormone levels fluctuate significantly during this stage, diagnosis and treatment require careful clinical evaluation rather than relying solely on a single laboratory measurement.
Why Symptoms Occur
Estrogen and progesterone receptors exist throughout the body. These receptors influence thermoregulation, neurotransmitter activity, bone remodeling, vascular function, and metabolic signaling. When hormone levels decline, multiple physiological systems are affected.
These changes can influence:
- Thermoregulation in the hypothalamus (leading to hot flashes)
- Sleep architecture
- Neurotransmitter balance affecting mood and cognition
- Metabolic function and fat distribution
- Vaginal and urinary tract tissue health
Menopausal symptoms therefore represent predictable physiological responses to hormonal change rather than isolated conditions.
Common Menopause Symptoms
Symptoms vary widely among individuals. Some women experience minimal disruption, while others experience symptoms that significantly affect daily life.
Common symptoms include:
- Hot flashes and night sweats
- Sleep disruption
- Mood changes or anxiety
- Brain fog and difficulty concentrating
- Vaginal dryness or discomfort
- Reduced libido
- Weight redistribution or metabolic change
- Joint discomfort or fatigue
Vasomotor symptoms alone may persist for seven to ten years in some women. Studies estimate that up to 75% of women experience hot flashes, and for roughly one-third of women these symptoms are severe enough to disrupt daily life.
Evidence for Hormone Therapy
Hormone replacement therapy for menopause remains the most effective treatment for vasomotor symptoms. Randomized controlled trials consistently demonstrate reductions in hot flash frequency of 70–90% compared with placebo.
Evidence also supports broader health benefits:
Bone Health
Estrogen preserves bone density and reduces fracture risk.
Cardiovascular Health
When initiated within the appropriate window, hormone therapy may support endothelial function and healthy lipid profiles.
Metabolic Health
Hormone therapy may reduce visceral fat accumulation and insulin resistance in some patients.
Quality of Life
Many women report improved sleep, mood, energy levels, and sexual health.
The Timing Hypothesis
Research suggests that the timing of hormone therapy initiation affects the overall risk‑benefit profile. The most favorable outcomes generally occur when therapy begins:
• Within 10 years of menopause onset
• Before age 60
This concept—often called the “window of opportunity”—is widely recognized in modern menopause care. When initiated within this window, hormone therapy may also support cardiovascular health and bone density preservation.
Understanding the Risks
Much of the public concern surrounding hormone therapy stems from early interpretations of the Women's Health Initiative (WHI) study published in 2002. Subsequent analyses have clarified that risk profiles depend heavily on age, timing of initiation, hormone formulation, and delivery method.
For most healthy women within 10 years of menopause onset, current evidence indicates that the benefits of therapy for symptom relief generally outweigh potential risks, particularly when transdermal estrogen and micronized progesterone are used.
Hormone Replacement Therapy Options for Menopause
Modern hormone replacement therapy for menopause may include several hormones depending on symptoms and physiology.
Estrogen
The primary therapy for vasomotor symptoms. Estrogen has different metabolic and clinical effects, and route of administration should be individualized based on symptoms, history, and risk profile.
Progesterone
Required for women with a uterus to protect the endometrial lining. Micronized progesterone is often favored because it is well tolerated, and some women report that it may also support sleep quality.
Testosterone
In carefully selected cases, low-dose testosterone may be considered to support sexual desire in postmenopausal women, particularly when HSDD (hypoactive sexual desire disorder) is present.
DHEA
Vaginal DHEA may improve genitourinary symptoms such as vaginal dryness or discomfort.
Weight & Body Composition
Current evidence suggests hormone therapy does not cause weight gain and may help mitigate some of the body composition and metabolic changes associated with menopause in certain women.
Treatment decisions should always be individualized and guided by a qualified physician.
Delivery Methods of Hormone Therapy
Hormone therapy can be delivered in multiple forms, each with advantages depending on patient physiology and goals.
Common delivery methods include:
• Transdermal patches
• Topical creams or gels
• Oral medications
• Vaginal estrogen preparations
• Subcutaneous pellets (in selected cases)
Choosing the optimal delivery method requires consideration of safety, symptom profile, and patient preference.
Laboratory Testing and Evaluation
Before beginning hormone therapy, a comprehensive medical evaluation is essential. Physicians may evaluate several biomarkers to better understand hormonal status and overall metabolic health, including:
• Estradiol
• Progesterone
• Testosterone
• Sex Hormone Binding Globulin (SHBG)
• Thyroid function markers
• Lipid profiles
• Metabolic markers such as glucose and insulin
Laboratory testing alone does not determine treatment decisions, but it can provide valuable context when interpreted alongside symptoms and medical history.
Is Hormone Therapy Right for You?
Hormone therapy may be appropriate for women who:
• Experience moderate to severe menopausal symptoms
• Are within 10 years of menopause onset
• Are younger than 60
• Seek treatment for hot flashes, sleep disruption, or vaginal symptoms
However, hormone therapy is not appropriate for everyone. Women with certain medical conditions—including active breast cancer, unexplained vaginal bleeding, or specific clotting disorders—may require alternative treatment strategies.
A comprehensive medical evaluation is essential to determine whether hormone therapy is appropriate for each individual.
What to Expect at Your First Metriq Visit
At Metriq Health, the menopause evaluation process is designed to be thorough, personalized, and physician‑led.
During an initial consultation, patients can expect:
• A comprehensive review of symptoms and medical history
• Discussion of lifestyle factors affecting hormonal health
• Evaluation of laboratory and metabolic markers
• A personalized treatment plan tailored to individual physiology
Ongoing follow‑up ensures therapy remains optimized as physiology and health goals evolve.
The Metriq Health Approach
At Metriq Health, menopause care is delivered through a precision medicine framework.
Many women receive incomplete menopause care because hormonal medicine is rarely emphasized in standard medical training. Metriq Health was created to provide specialized expertise in this area. Our physicians emphasize:
• Comprehensive medical evaluation
• Advanced biomarker analysis
• Individualized hormone protocols
• Evidence‑based treatment decisions
• Structured follow‑up and monitoring
Rather than applying standardized protocols, treatment plans are tailored to each patient’s physiology, symptoms, and long‑term health goals. This physician‑led approach allows women to navigate menopause with clarity, confidence, and a care plan designed to support long‑term healthspan.
Frequently Asked Questions
Reclaiming Health During the Menopause Transition
Menopause represents a major physiological transition, but it does not have to mean years of disrupted sleep, fatigue, cognitive fog, or declining vitality.
With evidence-based care, thoughtful evaluation, and individualized hormone protocols, many women experience meaningful improvements in symptoms, quality of life, and long-term health.
The goal of modern menopause care is not simply symptom suppression: it is helping women maintain energy, cognitive clarity, metabolic health, and wellbeing through midlife and beyond.
Clinical References
Major medical organizations supporting individualized menopause care include:
• The Menopause Society (formerly North American Menopause Society)
• American College of Obstetricians and Gynecologists (ACOG)
• Endocrine Society
Selected research references:
Rossouw JE et al. Women's Health Initiative Randomized Trial. JAMA. 2002.
Manson JE et al. Menopausal Hormone Therapy and Health Outcomes. JAMA. 2017.
The Menopause Society Position Statement on Hormone Therapy. 2022.
Medically reviewed by:
Tom Anderson, MD
Chief Medical Officer, Metriq Health
